IGF-DES 1mg:

IGF-DES 1 mg – Product Description

Overview:
IGF-DES (also known as IGF-1 DES 1–3) is a synthetic peptide fragment of insulin-like growth factor-1. It is a modified form of Insulin-like growth factor 1 designed to act more rapidly and locally in experimental research settings. A 1 mg vial typically refers to a lyophilized (freeze-dried) peptide used for laboratory research only.

Key Features:

• Active Compound: IGF-1 DES (1–3 analog)
• Strength: 1 mg per vial
• Form: Freeze-dried powder
• Class: IGF-1 analog peptide
• Category: Research chemical (not approved for medical use)

Mechanism of Action (Research Context):

IGF-DES is a shortened version of IGF-1 with a modified structure that:

• Has reduced binding to IGF-binding proteins (IGFBPs)
• Allows faster, more localized receptor activity
• Activates IGF-1 receptors more quickly in experimental models

This leads to interest in studies involving:

• Cell growth signaling
• Muscle tissue regeneration models
• Localized anabolic activity in lab research

Common Research Applications:

• Muscle cell and tissue growth studies
• Regeneration and repair signaling research
• Cellular metabolism and proliferation experiments
• Comparative studies with full-length IGF-1

Key Characteristics:

• Faster acting than full-length IGF-1 in experimental models
• Shorter half-life due to reduced binding protein interaction
• Often studied for localized vs systemic growth signaling effects

Potential Risks & Safety Concerns:

• Not approved for human or veterinary use
• Limited to preclinical and laboratory research
• Potential risks (based on IGF pathway activity):
  • Abnormal cell growth signaling
  • Hypoglycemia risk in systemic exposure
  • Unknown long-term safety profile
• Quality varies significantly in unregulated markets

Handling & Storage:

• Supplied as sterile lyophilized powder
• Requires reconstitution with sterile solution for research use
• Typically stored refrigerated (2–8 °C) after mixing

Legal Status:

IGF-DES is generally classified as a research-use-only peptide and is not approved as a therapeutic drug in most countries.

Important Note:

This information is for educational and research purposes only. IGF-DES is an experimental compound with limited human data, and any non-research use may carry significant health risks.